Form 4: Definitive Healthcare CFO Granted Significant Equity Award, Boosting Beneficial Ownership

Definitive Healthcare Corp.'s Chief Financial Officer, Casey Heller, was granted 498,339 restricted stock units, increasing her beneficial ownership to 605,084 shares.

Summary

• Casey Heller, Chief Financial Officer of Definitive Healthcare Corp. (DH), reported an acquisition of securities.
• On June 2, 2025, Ms. Heller was granted 498,339 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• These RSUs were granted at a price of $0 per share, as is typical for such equity awards.
• Following this transaction, Ms. Heller's total beneficial ownership of Class A Common Stock increased to 605,084 shares.
• The RSUs have a vesting schedule: 50% will vest on June 1, 2026, followed by 12.5% vesting every three months thereafter over the subsequent twelve months, contingent upon her continued service with the Issuer.

Sentiment

Score: 7

Explanation: The grant of a significant equity award to a key executive is generally viewed positively as it aligns management's interests with shareholders and incentivizes long-term performance and retention.

Positives

• The grant of 498,339 restricted stock units to the Chief Financial Officer significantly aligns her long-term financial interests with those of the company's shareholders.
• This equity award serves as a strong incentive for executive retention and continued performance, as vesting is subject to ongoing service.

Future Outlook

The vesting schedule for the granted Restricted Stock Units extends through June 2027, indicating an expectation of continued service from the Chief Financial Officer and a long-term incentive structure.

Industry Context

This Form 4 filing is a standard disclosure of an insider transaction, specifically an executive equity grant. Such grants are common practice across industries to compensate and incentivize key management personnel, aligning their interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The significant equity grant to the CFO enhances alignment between executive compensation and shareholder interests, potentially fostering long-term value creation.
• Employees: May signal stability and confidence in the company's leadership and future direction, potentially boosting morale.

Next Steps

• Vesting of 50% of the granted RSUs on June 1, 2026.
• Subsequent vesting of 12.5% of the RSUs every three months thereafter over the subsequent twelve months, subject to continued service.

Key Dates

Keywords

Definitive Healthcare, DH, Form 4, SEC filing, Restricted Stock Units, RSU, equity grant, executive compensation, insider transaction, CFO, beneficial ownership